Cart
sales@molnova.com
Nitroarginine
CAS No. 2149-70-4
Nitroarginine( N'-Nitro-L-arginine )
Catalog No. M28643 CAS No. 2149-70-4
Nitroarginine is a competitive inhibitor of nitric oxide synthase which causes the selective reduction of blood flow to tumor cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | 642 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNitroarginine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNitroarginine is a competitive inhibitor of nitric oxide synthase which causes the selective reduction of blood flow to tumor cells.
-
DescriptionNitroarginine is a competitive inhibitor of nitric oxide synthase which causes the selective reduction of blood flow to tumor cells.
-
In Vitro——
-
In Vivo——
-
SynonymsN'-Nitro-L-arginine
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorRARβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2149-70-4
-
Formula Weight219.2
-
Molecular FormulaC6H13N5O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN[C@@H](CCCNC(N[N+]([O-])=O)=N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lund BW, et al. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist. J Med Chem. 2005 Dec 1;48(24):7517-9.
molnova catalog
related products
-
Tsugaric acid A
Tsugaric acid A can significantly inhibit superoxide anion formation in fMLP/CB-stimulated rat neutrophils it is also able to protect human keratinocytes against damage induced by ultraviolet B (UV B) light indicates that tsugaric acid A can protect keratinocytes from photodamage.
-
SDMA
SDMA (Symmetric dimethylarginine) is an arginine derivative and an endogenous inhibitor of nitric oxide (NO) synthase activity.
-
Syringin
Syringin has antitumour, antiproliferative, immunomodulatory and platelet aggregation inhibiting effects. Syringin can prevent Abeta(25-35)-induced neuronal cell damage.
